{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:38:57Z","timestamp":1793093937840,"version":"4.5.0"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe, life-threatening hypersensitivity reactions most often induced by systemic medications. Reports of SJS\/TEN caused by topical ophthalmic sulfonamide-derived carbonic anhydrase inhibitors, such as brinzolamide, are extremely rare.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 31-year-old man underwent pars plana vitrectomy for traumatic retinal detachment in the right eye and subsequently developed secondary glaucoma. He was treated with topical brinzolamide 1% twice daily. On day 6 of treatment, he developed high-grade fever and erythema on the upper limbs, which rapidly progressed to widespread edematous erythema, bullae, epidermal detachment, and erosions involving 99% of the total body surface area. Ocular involvement was asymmetric: the right eye showed eyelid ulceration and conjunctival hyperemia, while the left eye had more severe manifestations, including marked conjunctival chemosis and extensive corneal epithelial sloughing.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnosis:<\/jats:title>\n                    <jats:p>\n                      Laboratory tests revealed leukopenia, elevated C-reactive protein, abnormal liver enzymes, and hypoalbuminemia. Blood cultures grew\n                      <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">Streptococcus<\/jats:italic>\n                      species. Causality assessment demonstrated a Naranjo score of 7 and an ALDEN score of 5, indicating a probable relationship between brinzolamide and SJS\/TEN overlap syndrome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The patient was treated with intravenous immunoglobulin, systemic corticosteroids, broad-spectrum antibiotics, antifungal therapy, supportive care, and ocular surface protection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>Over 4 weeks, cutaneous lesions resolved with residual hyperpigmentation. The left eye developed symblepharon and dense corneal scarring, requiring penetrating keratoplasty, resulting in postoperative visual acuity improvement to 0.05. The right eye remained without light perception due to preexisting retinal detachment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Topical ocular administration of sulfonamide-based drugs may trigger life-threatening systemic hypersensitivity reactions. Thorough allergy history and human leukocyte antigen genotyping should be considered before prescribing. Early recognition of prodromal symptoms, particularly ocular signs, and prompt multidisciplinary intervention are critical to preventing severe complications and irreversible vision loss.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000046362","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:00:46Z","timestamp":1764972046000},"page":"e46362","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Ocular administration of brinzolamide leading to Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap: A case report and review"],"prefix":"10.1097","volume":"104","author":[{"given":"Huayi","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingrui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Discipline Planning Management Office, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-6880","authenticated-orcid":false,"given":"Sen","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui Province, China"},{"name":"Department of Ophthalmology, Leiden University Medical Center (LUMC), Leiden, The Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archderm.1976.01630280041010","article-title":"Stevens-Johnson syndrome from ophthalmic sulfonamide.","volume":"112","author":"Gottschalk","year":"1976","journal-title":"Arch Dermatol"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s40123-023-00725-w","article-title":"Ophthalmic aspects of Stevens-Johnson syndrome and toxic epidermal necrolysis: a narrative review.","volume":"12","author":"T\u00f3th","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immu"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"173.e1","DOI":"10.1016\/j.jaad.2013.05.003","article-title":"Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis.","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"2040622319894469","DOI":"10.1177\/2040622319894469","article-title":"Multidisciplinary care in Stevens-Johnson syndrome.","volume":"11","author":"Shanbhag","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR study.","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Investig Dermatol"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1038\/srep04862","article-title":"Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement.","volume":"4","author":"Ueta","year":"2014","journal-title":"Sci Rep"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yebeh.2010.08.007","article-title":"Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.","volume":"19","author":"Wu","year":"2010","journal-title":"Epilepsy Behav"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0755-4982(05)83987-9","article-title":"Systemic adverse effects of topical ocular treatments.","volume":"34","author":"Labetoulle","year":"2005","journal-title":"Presse Med"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajo.2016.03.020","article-title":"Ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis in children.","volume":"166","author":"Catt","year":"2016","journal-title":"Am J Ophthalmol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:01:11Z","timestamp":1779530471000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":12,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046362","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-08-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}